Dräger | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

189 results for “Dräger”

Trials

View all 121 →

Dräger COVID-19 Antigen Test Clinical Performance Study

388 participants · First posted Jan 7, 2021

A Comparison Between the Aysis® Cs2 (General Electrics) Ventilator in EtControl® Mode and the Perseus® A 500 (Dräger) in VaporView® Mode on Maniability and Consumption of Desflurane

60 participants · First posted Apr 28, 2015

Enrolling By Invitation

The Impact of Sedation Depth Monitoring for Cognitive Functions and Early Rehabilitation After Major Joints Arthroplasty

100 participants · First posted Feb 5, 2024

Drugs

View all 11 →

FUSION DRIVER (Remix Therapeutics)

driver oncogene inhibitor (breast cancer)

Poliomyelitis Vaccine Dragee Candy，Live

Rx

Organizations

View all 10 →

Drägerwerk AG & Co. KGaA

Germany

KROGER COMPANY

United States

DRIVER REHABILITATION

United States

News

View all 47 →

Draeger Receives FDA 510(k) Clearance for Evita V800 Software 3.10 with Advanced ARDS Ventilation Features

Sibel Health Secures $30 Million Series C Funding and New FDA Clearance for Interoperable Monitoring Platform

Computer Modeling Identifies Two Broad-Spectrum Antiviral Compounds Against RNA Viruses

Page 1 of 19